XML 64 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Net loss attributable to Adaptive Biotechnologies Corporation $ (47,507) $ (57,699)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 145,787,527 143,511,142
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.33) $ (0.40)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 145,787,527 143,511,142
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.33) $ (0.40)